iSirona Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • iSirona's estimated annual revenue is currently $8.6M per year.(i)
  • iSirona's estimated revenue per employee is $216,000

Employee Data

  • iSirona has 40 Employees.(i)
  • iSirona grew their employee count by -11% last year.

iSirona's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$54.4M1836%N/AN/A
#2
$18M74-4%N/AN/A
#3
$162.7M48239%N/AN/A
#4
$42.8M1448%N/AN/A
#5
$26.5M984%N/AN/A
#6
$33.2M123-2%N/AN/A
#7
$29.7M11012%N/AN/A
#8
$15.5M66-21%$29.7MN/A
#9
$1645.8M435413%N/AN/A
#10
$43.7M14718%N/AN/A
Add Company

What Is iSirona?

iSirona provides a simplified approach to medical device integration by connecting virtually any medical device to any CIS. The iSirona solution gives clinicians faster access to more accurate information, empowering them to make more-informed decisions. As of January 1, 2014, iSirona became a part of NantHealth. NantHealth is a healthcare IT company that combines science, technology and data to provide actionable information that enables better diagnostics, improved patient care and advanced wellness for all. This partnership expands iSirona's ability to bring exciting, forward-thinking solutions to iSirona clients—and to the healthcare marketplace at large.

keywords:N/A

N/A

Total Funding

40

Number of Employees

$8.6M

Revenue (est)

-11%

Employee Growth %

N/A

Valuation

N/A

Accelerator

iSirona News

2022-04-17 - New JAMA Article Highlights the Outcome and Safety Benefits ...

... and include Iris® Gateway, iSirona™, Patient SafetyNet, Replica®, Halo ION™, UniView®, UniView :60™, and Masimo SafetyNet®.

2022-04-13 - Masimo Closes Acquisition of Sound United | Your Money ...

... and include Iris ® Gateway, iSirona™, Patient SafetyNet, Replica ®, Halo ION™, UniView ®, UniView :60™, and Masimo SafetyNet ®.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.8M40-31%N/A
#2
N/A4029%N/A
#3
$4.8M403%N/A
#4
$10.3M400%N/A
#5
$8.6M40-33%N/A